Gene symbol: Tfap2b

Also known as: Tcfap2b; AP2-beta; AP-2(beta); E130018K07Rik

Organism: Mus musculus

Summary: Enables DNA-binding transcription activator activity, RNA polymerase II-specific and RNA polymerase II cis-regulatory region sequence-specific DNA binding activity. Involved in several processes, including artery morphogenesis; inorganic ion homeostasis; and limb morphogenesis. Acts upstream of with a negative effect on negative regulation of apoptotic process. Acts upstream of or within several processes, including animal organ development; fat cell differentiation; and sympathetic nervous system development. Predicted to be active in nucleus. Is expressed in several structures, including genital tubercle; jaw; metanephros; nervous system; and sensory organ. Used to study Char syndrome; angle-closure glaucoma; and patent ductus arteriosus. Human ortholog(s) of this gene implicated in Char syndrome and patent ductus arteriosus. Orthologous to human TFAP2B (transcription factor AP-2 beta). [provided by Alliance of Genome Resources, Apr 2022]

NCBI gene ID: 21419 Ensembl:ENSMUSG00000025927 AllianceGenome:MGI:104672


GO Annotation


Category Term ID Term description
Process GO:0000122 Negative regulation of transcription by RNA polymerase II
Process GO:0001568 Blood vessel development
Process GO:0001654 Eye development
Process GO:0001655 Urogenital system development
Process GO:0001656 Metanephros development
Process GO:0001822 Kidney development
Process GO:0001944 Vasculature development
Process GO:0002791 Regulation of peptide secretion
Process GO:0003008 System process
Process GO:0003014 Renal system process
Process GO:0003091 Renal water homeostasis
Process GO:0003407 Neural retina development
Process GO:0005975 Carbohydrate metabolic process
Process GO:0005996 Monosaccharide metabolic process
Process GO:0006006 Glucose metabolic process
Process GO:0006139 Nucleobase-containing compound metabolic process
Process GO:0006351 Transcription, DNA-templated
Process GO:0006355 Regulation of transcription, DNA-templated
Process GO:0006357 Regulation of transcription by RNA polymerase II
Process GO:0006366 Transcription by RNA polymerase II
Process GO:0006725 Cellular aromatic compound metabolic process
Process GO:0006807 Nitrogen compound metabolic process
Process GO:0006873 Cellular ion homeostasis
Process GO:0006915 Apoptotic process
Process GO:0007275 Multicellular organism development
Process GO:0007399 Nervous system development
Process GO:0007423 Sensory organ development
Process GO:0008152 Metabolic process
Process GO:0008219 Cell death
Process GO:0008284 Positive regulation of cell population proliferation
Process GO:0008285 Negative regulation of cell population proliferation
Process GO:0009058 Biosynthetic process
Process GO:0009059 Macromolecule biosynthetic process
Process GO:0009410 Response to xenobiotic stimulus
Process GO:0009653 Anatomical structure morphogenesis
Process GO:0009887 Animal organ morphogenesis
Process GO:0009888 Tissue development
Process GO:0009889 Regulation of biosynthetic process
Process GO:0009890 Negative regulation of biosynthetic process
Process GO:0009891 Positive regulation of biosynthetic process
Process GO:0009892 Negative regulation of metabolic process
Process GO:0009893 Positive regulation of metabolic process
Process GO:0009966 Regulation of signal transduction
Process GO:0009987 Cellular process
Process GO:0010467 Gene expression
Process GO:0010468 Regulation of gene expression
Process GO:0010556 Regulation of macromolecule biosynthetic process
Process GO:0010557 Positive regulation of macromolecule biosynthetic process
Process GO:0010558 Negative regulation of macromolecule biosynthetic process
Process GO:0010604 Positive regulation of macromolecule metabolic process
Process GO:0010605 Negative regulation of macromolecule metabolic process
Process GO:0010646 Regulation of cell communication
Process GO:0010817 Regulation of hormone levels
Process GO:0010842 Retina layer formation
Process GO:0010941 Regulation of cell death
Process GO:0010942 Positive regulation of cell death
Process GO:0010960 Magnesium ion homeostasis
Process GO:0012501 Programmed cell death
Process GO:0016070 RNA metabolic process
Process GO:0018130 Heterocycle biosynthetic process
Process GO:0019219 Regulation of nucleobase-containing compound metabolic process
Process GO:0019222 Regulation of metabolic process
Process GO:0019318 Hexose metabolic process
Process GO:0019438 Aromatic compound biosynthetic process
Process GO:0019725 Cellular homeostasis
Process GO:0023051 Regulation of signaling
Process GO:0030003 Cellular cation homeostasis
Process GO:0030004 Cellular monovalent inorganic cation homeostasis
Process GO:0030104 Water homeostasis
Process GO:0030154 Cell differentiation
Process GO:0030510 Regulation of BMP signaling pathway
Process GO:0031323 Regulation of cellular metabolic process
Process GO:0031324 Negative regulation of cellular metabolic process
Process GO:0031325 Positive regulation of cellular metabolic process
Process GO:0031326 Regulation of cellular biosynthetic process
Process GO:0031327 Negative regulation of cellular biosynthetic process
Process GO:0031328 Positive regulation of cellular biosynthetic process
Process GO:0032501 Multicellular organismal process
Process GO:0032502 Developmental process
Process GO:0032774 RNA biosynthetic process
Process GO:0032879 Regulation of localization
Process GO:0032880 Regulation of protein localization
Process GO:0033500 Carbohydrate homeostasis
Process GO:0034641 Cellular nitrogen compound metabolic process
Process GO:0034654 Nucleobase-containing compound biosynthetic process
Process GO:0035107 Appendage morphogenesis
Process GO:0035108 Limb morphogenesis
Process GO:0035136 Forelimb morphogenesis
Process GO:0035137 Hindlimb morphogenesis
Process GO:0035239 Tube morphogenesis
Process GO:0035295 Tube development
Process GO:0035809 Regulation of urine volume
Process GO:0035810 Positive regulation of urine volume
Process GO:0035904 Aorta development
Process GO:0035909 Aorta morphogenesis
Process GO:0042127 Regulation of cell population proliferation
Process GO:0042221 Response to chemical
Process GO:0042592 Homeostatic process
Process GO:0042593 Glucose homeostasis
Process GO:0042981 Regulation of apoptotic process
Process GO:0043010 Camera-type eye development
Process GO:0043065 Positive regulation of apoptotic process
Process GO:0043066 Negative regulation of apoptotic process
Process GO:0043067 Regulation of programmed cell death
Process GO:0043068 Positive regulation of programmed cell death
Process GO:0043069 Negative regulation of programmed cell death
Process GO:0043170 Macromolecule metabolic process
Process GO:0043523 Regulation of neuron apoptotic process
Process GO:0043524 Negative regulation of neuron apoptotic process
Process GO:0043525 Positive regulation of neuron apoptotic process
Process GO:0043588 Skin development
Process GO:0044237 Cellular metabolic process
Process GO:0044238 Primary metabolic process
Process GO:0044249 Cellular biosynthetic process
Process GO:0044271 Cellular nitrogen compound biosynthetic process
Process GO:0044281 Small molecule metabolic process
Process GO:0045444 Fat cell differentiation
Process GO:0045595 Regulation of cell differentiation
Process GO:0045892 Negative regulation of transcription, DNA-templated
Process GO:0045893 Positive regulation of transcription, DNA-templated
Process GO:0045934 Negative regulation of nucleobase-containing compound metabolic process
Process GO:0045935 Positive regulation of nucleobase-containing compound metabolic process
Process GO:0045944 Positive regulation of transcription by RNA polymerase II
Process GO:0046483 Heterocycle metabolic process
Process GO:0046883 Regulation of hormone secretion
Process GO:0048483 Autonomic nervous system development
Process GO:0048485 Sympathetic nervous system development
Process GO:0048513 Animal organ development
Process GO:0048514 Blood vessel morphogenesis
Process GO:0048518 Positive regulation of biological process
Process GO:0048519 Negative regulation of biological process
Process GO:0048522 Positive regulation of cellular process
Process GO:0048523 Negative regulation of cellular process
Process GO:0048583 Regulation of response to stimulus
Process GO:0048592 Eye morphogenesis
Process GO:0048593 Camera-type eye morphogenesis
Process GO:0048646 Anatomical structure formation involved in morphogenesis
Process GO:0048731 System development
Process GO:0048736 Appendage development
Process GO:0048745 Smooth muscle tissue development
Process GO:0048844 Artery morphogenesis
Process GO:0048856 Anatomical structure development
Process GO:0048869 Cellular developmental process
Process GO:0048871 Multicellular organismal homeostasis
Process GO:0048878 Chemical homeostasis
Process GO:0048880 Sensory system development
Process GO:0050708 Regulation of protein secretion
Process GO:0050789 Regulation of biological process
Process GO:0050793 Regulation of developmental process
Process GO:0050794 Regulation of cellular process
Process GO:0050796 Regulation of insulin secretion
Process GO:0050801 Ion homeostasis
Process GO:0050878 Regulation of body fluid levels
Process GO:0050891 Multicellular organismal water homeostasis
Process GO:0050896 Response to stimulus
Process GO:0051046 Regulation of secretion
Process GO:0051049 Regulation of transport
Process GO:0051171 Regulation of nitrogen compound metabolic process
Process GO:0051172 Negative regulation of nitrogen compound metabolic process
Process GO:0051173 Positive regulation of nitrogen compound metabolic process
Process GO:0051223 Regulation of protein transport
Process GO:0051252 Regulation of RNA metabolic process
Process GO:0051253 Negative regulation of RNA metabolic process
Process GO:0051254 Positive regulation of RNA metabolic process
Process GO:0051402 Neuron apoptotic process
Process GO:0055062 Phosphate ion homeostasis
Process GO:0055065 Metal ion homeostasis
Process GO:0055067 Monovalent inorganic cation homeostasis
Process GO:0055074 Calcium ion homeostasis
Process GO:0055075 Potassium ion homeostasis
Process GO:0055078 Sodium ion homeostasis
Process GO:0055080 Cation homeostasis
Process GO:0055081 Anion homeostasis
Process GO:0055082 Cellular chemical homeostasis
Process GO:0060041 Retina development in camera-type eye
Process GO:0060042 Retina morphogenesis in camera-type eye
Process GO:0060173 Limb development
Process GO:0060255 Regulation of macromolecule metabolic process
Process GO:0060341 Regulation of cellular localization
Process GO:0060429 Epithelium development
Process GO:0060537 Muscle tissue development
Process GO:0060548 Negative regulation of cell death
Process GO:0060840 Artery development
Process GO:0061326 Renal tubule development
Process GO:0065007 Biological regulation
Process GO:0065008 Regulation of biological quality
Process GO:0070201 Regulation of establishment of protein localization
Process GO:0070997 Neuron death
Process GO:0071704 Organic substance metabolic process
Process GO:0072001 Renal system development
Process GO:0072006 Nephron development
Process GO:0072009 Nephron epithelium development
Process GO:0072017 Distal tubule development
Process GO:0072044 Collecting duct development
Process GO:0072073 Kidney epithelium development
Process GO:0072080 Nephron tubule development
Process GO:0072210 Metanephric nephron development
Process GO:0072359 Circulatory system development
Process GO:0072506 Trivalent inorganic anion homeostasis
Process GO:0072507 Divalent inorganic cation homeostasis
Process GO:0080090 Regulation of primary metabolic process
Process GO:0090087 Regulation of peptide transport
Process GO:0090092 Regulation of transmembrane receptor protein serine/threonine kinase signaling pathway
Process GO:0090276 Regulation of peptide hormone secretion
Process GO:0090287 Regulation of cellular response to growth factor stimulus
Process GO:0090304 Nucleic acid metabolic process
Process GO:0090596 Sensory organ morphogenesis
Process GO:0097070 Ductus arteriosus closure
Process GO:0097272 Ammonium homeostasis
Process GO:0097273 Creatinine homeostasis
Process GO:0097274 Urea homeostasis
Process GO:0097275 Cellular ammonium homeostasis
Process GO:0097276 Cellular creatinine homeostasis
Process GO:0097277 Cellular urea homeostasis
Process GO:0097659 Nucleic acid-templated transcription
Process GO:0098771 Inorganic ion homeostasis
Process GO:0150063 Visual system development
Process GO:1901214 Regulation of neuron death
Process GO:1901215 Negative regulation of neuron death
Process GO:1901216 Positive regulation of neuron death
Process GO:1901360 Organic cyclic compound metabolic process
Process GO:1901362 Organic cyclic compound biosynthetic process
Process GO:1901576 Organic substance biosynthetic process
Process GO:1902679 Negative regulation of RNA biosynthetic process
Process GO:1902680 Positive regulation of RNA biosynthetic process
Process GO:1903506 Regulation of nucleic acid-templated transcription
Process GO:1903507 Negative regulation of nucleic acid-templated transcription
Process GO:1903508 Positive regulation of nucleic acid-templated transcription
Process GO:1903530 Regulation of secretion by cell
Process GO:2001141 Regulation of RNA biosynthetic process
Component GO:0005622 Intracellular anatomical structure
Component GO:0005634 Nucleus
Component GO:0043226 Organelle
Component GO:0043227 Membrane-bounded organelle
Component GO:0043229 Intracellular organelle
Component GO:0043231 Intracellular membrane-bounded organelle
Component GO:0110165 Cellular anatomical entity
Function GO:0000976 Transcription cis-regulatory region binding
Function GO:0000977 RNA polymerase II transcription regulatory region sequence-specific DNA binding
Function GO:0000978 RNA polymerase II cis-regulatory region sequence-specific DNA binding
Function GO:0000981 DNA-binding transcription factor activity, RNA polymerase II-specific
Function GO:0000987 Cis-regulatory region sequence-specific DNA binding
Function GO:0001067 Transcription regulatory region nucleic acid binding
Function GO:0001216 DNA-binding transcription activator activity
Function GO:0001228 DNA-binding transcription activator activity, RNA polymerase II-specific
Function GO:0003676 Nucleic acid binding
Function GO:0003677 DNA binding
Function GO:0003682 Chromatin binding
Function GO:0003690 Double-stranded DNA binding
Function GO:0003700 DNA-binding transcription factor activity
Function GO:0005488 Binding
Function GO:0005515 Protein binding
Function GO:0042802 Identical protein binding
Function GO:0042803 Protein homodimerization activity
Function GO:0043565 Sequence-specific DNA binding
Function GO:0046982 Protein heterodimerization activity
Function GO:0046983 Protein dimerization activity
Function GO:0097159 Organic cyclic compound binding
Function GO:0140110 Transcription regulator activity
Function GO:1901363 Heterocyclic compound binding
Function GO:1990837 Sequence-specific double-stranded DNA binding

Pathway annotation


Category Term ID Term description
RCTM MMU-212436 Generic Transcription Pathway
RCTM MMU-73857 RNA Polymerase II Transcription
RCTM MMU-74160 Gene expression (Transcription)
RCTM MMU-8864260 Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors
RCTM MMU-8866904 Negative regulation of activity of TFAP2 (AP-2) family transcription factors
RCTM MMU-8866907 Activation of the TFAP2 (AP-2) family of transcription factors
WikiPathways WP2074 Neural crest differentiation

Expression profile of Tfap2b in omics data



ID GSE106799
Title Propofol alters the mRNA profile in the developing mouse hippocampus
Organism Mus musculus
GSM Sample info Characteristics Value
GSM2850452 Control 1 tissue: hippocampus age: 7 days-old 7.950949
GSM2850453 Control 2 tissue: hippocampus age: 7 days-old 7.9353027
GSM2850454 Control 3 tissue: hippocampus age: 7 days-old 7.9934497
GSM2850455 Control 4 tissue: hippocampus age: 7 days-old 8.28029
GSM2850456 Propofol 1 tissue: hippocampus age: 7 days-old 7.8958755
GSM2850457 Propofol 2 tissue: hippocampus age: 7 days-old 7.5970526
GSM2850458 Propofol 3 tissue: hippocampus age: 7 days-old 7.7698474
GSM2850459 Propofol 4 tissue: hippocampus age: 7 days-old 7.9898467

ID GSE109165
Title Suppression of RGSz1 function optimizes the actions of opioid analgesics by mechanisms that involve the Wnt/β-catenin pathway
Organism Mus musculus
GSM Sample info Characteristics Value
GSM2934457 WT_Naive_1 tissue: brain brain region: Periaqueductal gray region Sex: Male genotype: wildtype treatment: naïve 1048.0
GSM2934458 WT_Naive_2 tissue: brain brain region: Periaqueductal gray region Sex: Male genotype: wildtype treatment: naïve 3304.0
GSM2934459 WT_Naive_3 tissue: brain brain region: Periaqueductal gray region Sex: Male genotype: wildtype treatment: naïve 3279.0
GSM2934460 WT_Naive_4 tissue: brain brain region: Periaqueductal gray region Sex: Male genotype: wildtype treatment: naïve 1344.0
GSM2934461 KO_Naive_1 tissue: brain brain region: Periaqueductal gray region Sex: Male genotype: RGSz1 KO treatment: naïve 2320.0
GSM2934462 KO_Naive_2 tissue: brain brain region: Periaqueductal gray region Sex: Male genotype: RGSz1 KO treatment: naïve 2219.0
GSM2934463 KO_Naive_3 tissue: brain brain region: Periaqueductal gray region Sex: Male genotype: RGSz1 KO treatment: naïve 1360.0
GSM2934464 KO_Naive_4 tissue: brain brain region: Periaqueductal gray region Sex: Male genotype: RGSz1 KO treatment: naïve 2326.0
GSM2934465 WT_Morphine_1 tissue: brain brain region: Periaqueductal gray region Sex: Male genotype: wildtype treatment: morphine 1196.0
GSM2934466 WT_Morphine_2 tissue: brain brain region: Periaqueductal gray region Sex: Male genotype: wildtype treatment: morphine 862.0
GSM2934467 WT_Morphine_3 tissue: brain brain region: Periaqueductal gray region Sex: Male genotype: wildtype treatment: morphine 1813.0
GSM2934468 WT_Morphine_4 tissue: brain brain region: Periaqueductal gray region Sex: Male genotype: wildtype treatment: morphine 1072.0
GSM2934469 KO_Morphine_1 tissue: brain brain region: Periaqueductal gray region Sex: Male genotype: RGSz1 KO treatment: morphine 1512.0
GSM2934470 KO_Morphine_2 tissue: brain brain region: Periaqueductal gray region Sex: Male genotype: RGSz1 KO treatment: morphine 599.0
GSM2934471 KO_Morphine_3 tissue: brain brain region: Periaqueductal gray region Sex: Male genotype: RGSz1 KO treatment: morphine 683.0
GSM2934472 KO_Morphine_4 tissue: brain brain region: Periaqueductal gray region Sex: Male genotype: RGSz1 KO treatment: morphine 1041.0

ID GSE125076
Title A mouse model of acute post-surgical pain
Organism Mus musculus
GSM Sample info Characteristics Value
GSM3562188 DRG_WT_sham_1 strain: C57BL/6 gender: male age: 8 weeks treatment: naïve 2.0
GSM3562189 DRG_WT_sham_2 strain: C57BL/6 gender: male age: 8 weeks treatment: naïve 0.0
GSM3562190 DRG_WT_sham_3 strain: C57BL/6 gender: male age: 8 weeks treatment: naïve 0.0
GSM3562191 DRG_WT_PSP_1 strain: C57BL/6 gender: male age: 8 weeks treatment: 24h post surgery 0.0
GSM3562192 DRG_WT_PSP_2 strain: C57BL/6 gender: male age: 8 weeks treatment: 24h post surgery 0.0
GSM3562193 DRG_WT_PSP_3 strain: C57BL/6 gender: male age: 8 weeks treatment: 24h post surgery 0.0

ID GSE126662
Title Comparison between opioid (morphine) and vehicle treatments in mouse trigeminal ganglia and nucleus accumbens
Organism Mus musculus
GSM Sample info Characteristics Value
GSM3610703 TG_M1: OIH_M1_Trigeminal_Ganglia tissue: Trigeminal ganglia strain: C57BL/6J treatment: OIH age: 9-12 weeks old Sex: male 1.1996383333333334
GSM3610704 TG_M2: OIH_M2_Trigeminal_Ganglia tissue: Trigeminal ganglia strain: C57BL/6J treatment: OIH age: 9-12 weeks old Sex: male 0.3143533333333333
GSM3610705 TG_M3: OIH_M3_Trigeminal_Ganglia tissue: Trigeminal ganglia strain: C57BL/6J treatment: OIH age: 9-12 weeks old Sex: male 0.90634
GSM3610706 TG_M4: OIH_M4_Trigeminal_Ganglia tissue: Trigeminal ganglia strain: C57BL/6J treatment: OIH age: 9-12 weeks old Sex: male 0.5586816666666666
GSM3610707 TG_M5: OIH_M5_Trigeminal_Ganglia tissue: Trigeminal ganglia strain: C57BL/6J treatment: OIH age: 9-12 weeks old Sex: male 2.7444395
GSM3610708 TG_V1: VehicleOIH_V1_Trigeminal_Ganglia tissue: Trigeminal ganglia strain: C57BL/6J treatment: Vehicle age: 9-12 weeks old Sex: male 2.9059111666666664
GSM3610709 TG_V2: VehicleOIH_V2_Trigeminal_Ganglia tissue: Trigeminal ganglia strain: C57BL/6J treatment: Vehicle age: 9-12 weeks old Sex: male 0.39179499999999995
GSM3610710 TG_V3: VehicleOIH_V3_Trigeminal_Ganglia tissue: Trigeminal ganglia strain: C57BL/6J treatment: Vehicle age: 9-12 weeks old Sex: male 0.855875
GSM3610711 TG_V4: VehicleOIH_V4_Trigeminal_Ganglia tissue: Trigeminal ganglia strain: C57BL/6J treatment: Vehicle age: 9-12 weeks old Sex: male 1.693876666666667
GSM3610712 TG_V5: VehicleOIH_V5_Trigeminal_Ganglia tissue: Trigeminal ganglia strain: C57BL/6J treatment: Vehicle age: 9-12 weeks old Sex: male 1.0350466666666667
GSM3610713 NAc_M1: OIH_M1_Nucleus_Accumbens tissue: Nucleus accumbens strain: C57BL/6J treatment: OIH age: 9-12 weeks old Sex: male 0.06993733333333334
GSM3610714 NAc_M2: OIH_M2_Nucleus_Accumbens tissue: Nucleus accumbens strain: C57BL/6J treatment: OIH age: 9-12 weeks old Sex: male 2.7209333333333334
GSM3610715 NAc_M3: OIH_M3_Nucleus_Accumbens tissue: Nucleus accumbens strain: C57BL/6J treatment: OIH age: 9-12 weeks old Sex: male 0.0
GSM3610716 NAc_M4: OIH_M4_Nucleus_Accumbens tissue: Nucleus accumbens strain: C57BL/6J treatment: OIH age: 9-12 weeks old Sex: male 4.863131666666667
GSM3610717 NAc_M5: OIH_M5_Nucleus_Accumbens tissue: Nucleus accumbens strain: C57BL/6J treatment: OIH age: 9-12 weeks old Sex: male 0.8415516666666667
GSM3610718 NAc_V1: VehicleOIH_V1_Nucleus_Accumbens tissue: Nucleus accumbens strain: C57BL/6J treatment: Vehicle age: 9-12 weeks old Sex: male 3.2168166666666664
GSM3610719 NAc_V2: VehicleOIH_V2_Nucleus_Accumbens tissue: Nucleus accumbens strain: C57BL/6J treatment: Vehicle age: 9-12 weeks old Sex: male 3.387408333333333
GSM3610720 NAc_V3: VehicleOIH_V3_Nucleus_Accumbens tissue: Nucleus accumbens strain: C57BL/6J treatment: Vehicle age: 9-12 weeks old Sex: male 1.0332166666666667
GSM3610721 NAc_V4: VehicleOIH_V4_Nucleus_Accumbens tissue: Nucleus accumbens strain: C57BL/6J treatment: Vehicle age: 9-12 weeks old Sex: male 3.967636666666667
GSM3610722 NAc_V5: VehicleOIH_V5_Nucleus_Accumbens tissue: Nucleus accumbens strain: C57BL/6J treatment: Vehicle age: 9-12 weeks old Sex: male 3.456099

ID GSE138802
Title Mesocorticolimbic circuit mechanisms underlying the effects of ketamine on dopamine: a translational imaging study
Organism Mus musculus
GSM Sample info Characteristics Value
GSM4119733 PLc_1_Sal strain: C57Bl/6 age: 9 weeks tissue: Pre-limbic cortex treatment: Saline 55.56
GSM4119734 PLc_10_Sal strain: C57Bl/6 age: 9 weeks tissue: Pre-limbic cortex treatment: Saline 15.37
GSM4119735 PLc_6_Sal strain: C57Bl/6 age: 9 weeks tissue: Pre-limbic cortex treatment: Saline 48.26
GSM4119736 PLc_5_Ket strain: C57Bl/6 age: 9 weeks tissue: Pre-limbic cortex treatment: Ketamine 37.63
GSM4119737 PLc_3_Ket strain: C57Bl/6 age: 9 weeks tissue: Pre-limbic cortex treatment: Ketamine 46.01
GSM4119738 PLc_9_Ket strain: C57Bl/6 age: 9 weeks tissue: Pre-limbic cortex treatment: Ketamine 71.61

ID GSE163828
Title Regulation of electro-acupuncture(EA) and astragalus membranaceus (AM) on genes in bone marrow
Organism Mus musculus
GSM Sample info Characteristics Value
GSM4988039 BH190126-1_control tissue: bone marrow 4.79
GSM4988040 BH190126-1_treatment of astragalus membranaceus tissue: bone marrow 4.7
GSM4988041 BH190126-1_cisplatin tissue: bone marrow 4.82
GSM4988042 BH190126-1_treatment of electro-acupuncture tissue: bone marrow 4.72

ID GSE20160
Title Gene Expression Data from Prefrontal Cortex and Nucleus Accumbens from Inbred Strains of Mice
Organism Mus musculus
GSM Sample info Characteristics Value
GSM505749 129S1/SvImJ_Male_Frontal_Cortex gender: male tissue: Frontal Cortex strain: 129S1/SvImJ 4.731999999999999
GSM505750 A/J_Male_Frontal_Cortex gender: male tissue: Frontal Cortex strain: A/J 4.7445
GSM505751 AKR/J_Male_Frontal_Cortex gender: male tissue: Frontal Cortex strain: AKR/J 4.744
GSM505752 BALB/cByJ_Male_Frontal_Cortex gender: male tissue: Frontal Cortex strain: BALB/cByJ 4.8045
GSM505753 BTBR_T+_tf/J_Male_Frontal_Cortex gender: male tissue: Frontal Cortex strain: BTBR_T+_tf/J 4.769500000000001
GSM505754 BUB/BnJ_Male_Frontal_Cortex gender: male tissue: Frontal Cortex strain: BUB/BnJ 4.803
GSM505755 C3H/HeJ_Male_Frontal_Cortex gender: male tissue: Frontal Cortex strain: C3H/HeJ 4.71
GSM505756 C57BL/6J_Male_Frontal_Cortex gender: male tissue: Frontal Cortex strain: C57BL/6J 4.8115000000000006
GSM505757 C57BR/cdJ_Male_Frontal_Cortex gender: male tissue: Frontal Cortex strain: C57BR/cdJ 4.779
GSM505758 C58/J_Male_Frontal_Cortex gender: male tissue: Frontal Cortex strain: C58/J 4.7765
GSM505759 CBA/J_Male_Frontal_Cortex gender: male tissue: Frontal Cortex strain: CBA/J 4.8115
GSM505760 CE/J_Male_Frontal_Cortex gender: male tissue: Frontal Cortex strain: CE/J 4.8415
GSM505761 DBA/2J_Male_Frontal_Cortex gender: male tissue: Frontal Cortex strain: DBA/2J 4.9735
GSM505762 FVB/NJ_Male_Frontal_Cortex gender: male tissue: Frontal Cortex strain: FVB/NJ 4.8625
GSM505763 I/LnJ_Male_Frontal_Cortex gender: male tissue: Frontal Cortex strain: I/LnJ 4.8575
GSM505764 KK/HlJ_Male_Frontal_Cortex gender: male tissue: Frontal Cortex strain: KK/HlJ 4.7844999999999995
GSM505765 MA/MyJ_Male_Frontal_Cortex gender: male tissue: Frontal Cortex strain: MA/MyJ 4.769
GSM505766 MRL_MpJ_Male_Frontal_Cortex gender: male tissue: Frontal Cortex strain: MRL/MpJ 4.702999999999999
GSM505767 NOD/LtJ_Male_Frontal_Cortex gender: male tissue: Frontal Cortex strain: NOD/LtJ 4.734500000000001
GSM505768 NON/LtJ_Male_Frontal_Cortex gender: male tissue: Frontal Cortex strain: NON/LtJ 4.854
GSM505769 NZO/HILtJ_Male_Frontal_Cortex gender: male tissue: Frontal Cortex strain: NZO/HILtJ 4.784000000000001
GSM505770 NZW_LacJ_Male_Frontal_Cortex gender: male tissue: Frontal Cortex strain: NZW_LacJ 4.7765
GSM505771 P/J_Male_Frontal_Cortex gender: male tissue: Frontal Cortex strain: P/J 4.92
GSM505772 PL/J_Male_Frontal_Cortex gender: male tissue: Frontal Cortex strain: PL/J 4.913
GSM505773 RIIIS/J_Male_Frontal_Cortex gender: male tissue: Frontal Cortex strain: RIIIS/J 4.8445
GSM505774 SJL/J_Male_Frontal_Cortex gender: male tissue: Frontal Cortex strain: SJL/J 4.85
GSM505775 SM/J_Male_Frontal_Cortex gender: male tissue: Frontal Cortex strain: SM/J 4.8245000000000005
GSM505776 SWR/J_Male_Frontal_Cortex gender: male tissue: Frontal Cortex strain: SWR/J 4.864
GSM505777 WSB/EiJ_Male_Frontal_Cortex gender: male tissue: Frontal Cortex strain: WSB/EiJ 4.8675
GSM505778 129S1/SvImJ_Male_Nuc_Acc gender: male tissue: Nucleus Accumbens strain: 129S1/SvImJ 4.7940000000000005
GSM505779 A/J_Male_Nuc_Acc gender: male tissue: Nucleus Accumbens strain: A/J 4.9165
GSM505780 AKR/J_Male_Nuc_Acc gender: male tissue: Nucleus Accumbens strain: AKR/J 4.821
GSM505781 BALB/cByJ_Male_Nuc_Acc gender: male tissue: Nucleus Accumbens strain: BALB/cByJ 4.85
GSM505782 BTBR_T+_tf/J_Male_Nuc_Acc gender: male tissue: Nucleus Accumbens strain: BTBR_T+_tf/J 4.8215
GSM505783 BUB/BnJ_Male_Nuc_Acc gender: male tissue: Nucleus Accumbens strain: BUB/BnJ 4.7535
GSM505784 C3H/HeJ_Male_Nuc_Acc gender: male tissue: Nucleus Accumbens strain: C3H/HeJ 4.782500000000001
GSM505785 C57BL/6J_Male_Nuc_Acc gender: male tissue: Nucleus Accumbens strain: C57BL/6J 4.846
GSM505786 C57BR/cdJ_Male_Nuc_Acc gender: male tissue: Nucleus Accumbens strain: C57BR/cdJ 4.872
GSM505787 C58/J_Male_Nuc_Acc gender: male tissue: Nucleus Accumbens strain: C58/J 4.824
GSM505788 CBA/J_Male_Nuc_Acc gender: male tissue: Nucleus Accumbens strain: CBA/J 4.773
GSM505789 CE/J_Male_Nuc_Acc gender: male tissue: Nucleus Accumbens strain: CE/J 4.8355
GSM505790 DBA/2J_Male_Nuc_Acc gender: male tissue: Nucleus Accumbens strain: DBA/2J 4.7835
GSM505791 FVB/NJ_Male_Nuc_Acc gender: male tissue: Nucleus Accumbens strain: FVB/NJ 4.87
GSM505792 I/LnJ_Male_Nuc_Acc gender: male tissue: Nucleus Accumbens strain: I/LnJ 4.768000000000001
GSM505793 KK/HlJ_Male_Nuc_Acc gender: male tissue: Nucleus Accumbens strain: KK/HlJ 4.7675
GSM505794 MA/MyJ_Male_Nuc_Acc gender: male tissue: Nucleus Accumbens strain: MA/MyJ 4.8309999999999995
GSM505795 NOD/LtJ_Male_Nuc_Acc gender: male tissue: Nucleus Accumbens strain: NOD/LtJ 4.7705
GSM505796 NON/LtJ_Male_Nuc_Acc gender: male tissue: Nucleus Accumbens strain: NON/LtJ 4.6845
GSM505797 NZW/LacJ_Male_Nuc_Acc gender: male tissue: Nucleus Accumbens strain: NZW/LacJ 4.729
GSM505798 P/J_Male_Nuc_Acc gender: male tissue: Nucleus Accumbens strain: P/J 4.7669999999999995
GSM505799 PL/J_Male_Nuc_Acc gender: male tissue: Nucleus Accumbens strain: PL/J 4.708
GSM505800 RIIIS/J_Male_Nuc_Acc gender: male tissue: Nucleus Accumbens strain: RIIIS/J 4.836499999999999
GSM505801 SJL/J_Male_Nuc_Acc gender: male tissue: Nucleus Accumbens strain: SJL/J 4.861
GSM505802 SM/J_Male_Nuc_Acc gender: male tissue: Nucleus Accumbens strain: SM/J 4.817
GSM505803 SWR/J_Male_Nuc_Acc gender: male tissue: Nucleus Accumbens strain: SWR/J 4.8755
GSM505804 WSB/EiJ_Male_Nuc_Acc gender: male tissue: Nucleus Accumbens strain: WSB/EiJ 4.9005

ID GSE205201
Title Hepatic responses of mice and rats to equivalent acetaminophen (APAP) insult [mouse]
Organism Mus musculus
GSM Sample info Characteristics Value
GSM6208462 Mouse_Baseline_0h_1 tissue: liver strain: C57Bl/6J Sex: male treatment: Untreated hours after treatment: 0 5.308687
GSM6208463 Mouse_Baseline_0h_2 tissue: liver strain: C57Bl/6J Sex: male treatment: Untreated hours after treatment: 0 5.480176
GSM6208464 Mouse_Baseline_0h_3 tissue: liver strain: C57Bl/6J Sex: male treatment: Untreated hours after treatment: 0 5.421494
GSM6208465 Mouse_Baseline_0h_4 tissue: liver strain: C57Bl/6J Sex: male treatment: Untreated hours after treatment: 0 5.541683
GSM6208466 Mouse_Baseline_0h_5 tissue: liver strain: C57Bl/6J Sex: male treatment: Untreated hours after treatment: 0 5.633369
GSM6208467 Mouse_Vehicle_03h_1 tissue: liver strain: C57Bl/6J Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 3 5.246946
GSM6208468 Mouse_Vehicle_03h_2 tissue: liver strain: C57Bl/6J Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 3 5.164423
GSM6208469 Mouse_Vehicle_03h_3 tissue: liver strain: C57Bl/6J Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 3 5.276444
GSM6208470 Mouse_Vehicle_03h_4 tissue: liver strain: C57Bl/6J Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 3 5.529023
GSM6208471 Mouse_Vehicle_03h_5 tissue: liver strain: C57Bl/6J Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 3 5.313415
GSM6208472 Mouse_Vehicle_06h_1 tissue: liver strain: C57Bl/6J Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 6 5.610015
GSM6208473 Mouse_Vehicle_06h_2 tissue: liver strain: C57Bl/6J Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 6 5.308649
GSM6208474 Mouse_Vehicle_06h_3 tissue: liver strain: C57Bl/6J Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 6 5.430967
GSM6208475 Mouse_Vehicle_06h_4 tissue: liver strain: C57Bl/6J Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 6 5.489412
GSM6208476 Mouse_Vehicle_06h_5 tissue: liver strain: C57Bl/6J Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 6 5.615752
GSM6208477 Mouse_Vehicle_09h_1 tissue: liver strain: C57Bl/6J Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 9 5.549932
GSM6208478 Mouse_Vehicle_09h_2 tissue: liver strain: C57Bl/6J Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 9 5.204894
GSM6208479 Mouse_Vehicle_09h_3 tissue: liver strain: C57Bl/6J Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 9 5.341013
GSM6208480 Mouse_Vehicle_09h_4 tissue: liver strain: C57Bl/6J Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 9 5.400503
GSM6208481 Mouse_Vehicle_09h_5 tissue: liver strain: C57Bl/6J Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 9 5.69643
GSM6208482 Mouse_Vehicle_24h_1 tissue: liver strain: C57Bl/6J Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 24 5.522622
GSM6208483 Mouse_Vehicle_24h_2 tissue: liver strain: C57Bl/6J Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 24 5.469911
GSM6208484 Mouse_Vehicle_24h_3 tissue: liver strain: C57Bl/6J Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 24 5.647684
GSM6208485 Mouse_Vehicle_24h_4 tissue: liver strain: C57Bl/6J Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 24 5.582515
GSM6208486 Mouse_Vehicle_24h_5 tissue: liver strain: C57Bl/6J Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 24 5.469911
GSM6208487 Mouse_APAP_03h_1 tissue: liver strain: C57Bl/6J Sex: male treatment: 300 mg/kg acetamnophen (o.g.) hours after treatment: 3 5.467338
GSM6208488 Mouse_APAP_03h_2 tissue: liver strain: C57Bl/6J Sex: male treatment: 300 mg/kg acetamnophen (o.g.) hours after treatment: 3 5.40351
GSM6208489 Mouse_APAP_03h_3 tissue: liver strain: C57Bl/6J Sex: male treatment: 300 mg/kg acetamnophen (o.g.) hours after treatment: 3 5.516241
GSM6208490 Mouse_APAP_03h_4 tissue: liver strain: C57Bl/6J Sex: male treatment: 300 mg/kg acetamnophen (o.g.) hours after treatment: 3 5.600036
GSM6208491 Mouse_APAP_03h_5 tissue: liver strain: C57Bl/6J Sex: male treatment: 300 mg/kg acetamnophen (o.g.) hours after treatment: 3 5.495377
GSM6208492 Mouse_APAP_06h_1 tissue: liver strain: C57Bl/6J Sex: male treatment: 300 mg/kg acetamnophen (o.g.) hours after treatment: 6 5.390646
GSM6208493 Mouse_APAP_06h_2 tissue: liver strain: C57Bl/6J Sex: male treatment: 300 mg/kg acetamnophen (o.g.) hours after treatment: 6 5.508916
GSM6208494 Mouse_APAP_06h_3 tissue: liver strain: C57Bl/6J Sex: male treatment: 300 mg/kg acetamnophen (o.g.) hours after treatment: 6 5.587298
GSM6208495 Mouse_APAP_06h_4 tissue: liver strain: C57Bl/6J Sex: male treatment: 300 mg/kg acetamnophen (o.g.) hours after treatment: 6 5.640889
GSM6208496 Mouse_APAP_06h_5 tissue: liver strain: C57Bl/6J Sex: male treatment: 300 mg/kg acetamnophen (o.g.) hours after treatment: 6 5.533849
GSM6208497 Mouse_APAP_09h_1 tissue: liver strain: C57Bl/6J Sex: male treatment: 300 mg/kg acetamnophen (o.g.) hours after treatment: 9 5.372155
GSM6208498 Mouse_APAP_09h_2 tissue: liver strain: C57Bl/6J Sex: male treatment: 300 mg/kg acetamnophen (o.g.) hours after treatment: 9 5.223806
GSM6208499 Mouse_APAP_09h_3 tissue: liver strain: C57Bl/6J Sex: male treatment: 300 mg/kg acetamnophen (o.g.) hours after treatment: 9 5.567228
GSM6208500 Mouse_APAP_09h_4 tissue: liver strain: C57Bl/6J Sex: male treatment: 300 mg/kg acetamnophen (o.g.) hours after treatment: 9 5.589476
GSM6208501 Mouse_APAP_09h_5 tissue: liver strain: C57Bl/6J Sex: male treatment: 300 mg/kg acetamnophen (o.g.) hours after treatment: 9 5.448993
GSM6208502 Mouse_APAP_24h_1 tissue: liver strain: C57Bl/6J Sex: male treatment: 300 mg/kg acetamnophen (o.g.) hours after treatment: 24 5.414197
GSM6208503 Mouse_APAP_24h_2 tissue: liver strain: C57Bl/6J Sex: male treatment: 300 mg/kg acetamnophen (o.g.) hours after treatment: 24 5.615181
GSM6208504 Mouse_APAP_24h_3 tissue: liver strain: C57Bl/6J Sex: male treatment: 300 mg/kg acetamnophen (o.g.) hours after treatment: 24 5.369863
GSM6208505 Mouse_APAP_24h_4 tissue: liver strain: C57Bl/6J Sex: male treatment: 300 mg/kg acetamnophen (o.g.) hours after treatment: 24 5.389733
GSM6208506 Mouse_APAP_24h_5 tissue: liver strain: C57Bl/6J Sex: male treatment: 300 mg/kg acetamnophen (o.g.) hours after treatment: 24 5.362457

ID GSE223541
Title Oxycodone withdrawal induces HDAC1/2-dependent transcriptional maladaptations in the reward pathway in a murine model of peripheral nerve injury
Organism Mus musculus
GSM Sample info Characteristics Value
GSM6958536 B1 tissue: Brain strain: C57BL/6 Sex: male cell type: Nac genotype: Sham condition: Sa 6.0
GSM6958537 C1 tissue: Brain strain: C57BL/6 Sex: male cell type: Nac genotype: Sham condition: oxy 6.0
GSM6958538 F1 tissue: Brain strain: C57BL/6 Sex: male cell type: Nac genotype: SNI condition: Sal 0.0
GSM6958539 H1 tissue: Brain strain: C57BL/6 Sex: male cell type: Nac genotype: SNI condition: oxy 9.0
GSM6958540 B2 tissue: Brain strain: C57BL/6 Sex: male cell type: Nac genotype: Sham condition: Sal 1.0
GSM6958541 C2 tissue: Brain strain: C57BL/6 Sex: male cell type: Nac genotype: Sham condition: oxy 2.0
GSM6958542 F2 tissue: Brain strain: C57BL/6 Sex: male cell type: Nac genotype: SNI condition: Sal 1.0
GSM6958543 H2 tissue: Brain strain: C57BL/6 Sex: male cell type: Nac genotype: SNI condition: oxy 1.0
GSM6958544 B3 tissue: Brain strain: C57BL/6 Sex: male cell type: Nac genotype: Sham condition: Sal 4.0
GSM6958545 C3 tissue: Brain strain: C57BL/6 Sex: male cell type: Nac genotype: Sham condition: oxy 4.0
GSM6958546 F3 tissue: Brain strain: C57BL/6 Sex: male cell type: Nac genotype: SNI condition: Sal 1.0
GSM6958547 H3 tissue: Brain strain: C57BL/6 Sex: male cell type: Nac genotype: SNI condition: oxy 2.0
GSM6958548 B4 tissue: Brain strain: C57BL/6 Sex: male cell type: Nac genotype: Sham condition: Sal 1.0
GSM6958549 C4 tissue: Brain strain: C57BL/6 Sex: male cell type: Nac genotype: Sham condition: oxy 0.0
GSM6958550 F4 tissue: Brain strain: C57BL/6 Sex: male cell type: Nac genotype: SNI condition: Sal 0.0
GSM6958551 H4 tissue: Brain strain: C57BL/6 Sex: male cell type: Nac genotype: SNI condition: oxy 4.0

ID GSE24829
Title Gene expression data from striatal regions of MPTP-intoxicated mouse brain by acupuncture
Organism Mus musculus
GSM Sample info Characteristics Value
GSM611081 Control mouse 1 striatal regions gender: Male strain: C57BL/6 tissue: Striatal tissues developmental stage: Adult treatment: Control 4.69706
GSM611082 Control mouse 2 striatal regions gender: Male strain: C57BL/6 tissue: Striatal tissues developmental stage: Adult treatment: Control 4.86593
GSM611083 MPTP-treated mouse 1 striatal regions gender: Male strain: C57BL/6 tissue: Striatal tissues developmental stage: Adult treatment: MPTP-treated 4.71109
GSM611084 MPTP-treated mouse 2 striatal regions gender: Male strain: C57BL/6 tissue: Striatal tissues developmental stage: Adult treatment: MPTP-treated 4.54749
GSM611085 MPTP and acupoints acupuncture-treated mouse 1 striatal regions gender: Male strain: C57BL/6 tissue: Striatal tissues developmental stage: Adult treatment: MPTP and acupoints acupuncture-treated 4.46335
GSM611086 MPTP and acupoints acupuncture-treated mouse 2 striatal regions gender: Male strain: C57BL/6 tissue: Striatal tissues developmental stage: Adult treatment: MPTP and acupoints acupuncture-treated 5.12315
GSM611087 MPTP and nonacupoints acupuncture-treated mouse 1 striatal regions gender: Male strain: C57BL/6 tissue: Striatal tissues developmental stage: Adult treatment: MPTP and nonacupoints acupuncture-treated 4.70307
GSM611088 MPTP and nonacupoints acupuncture-treated mouse 2 striatal regions gender: Male strain: C57BL/6 tissue: Striatal tissues developmental stage: Adult treatment: MPTP and nonacupoints acupuncture-treated 4.56652

ID GSE24830
Title Gene expression data from cervical spinal cord regions of MPTP-intoxicated mouse by acupuncture
Organism Mus musculus
GSM Sample info Characteristics Value
GSM611089 Control mouse 1 cervical spinal cord regions gender: Male strain: C57BL/6 tissue: Cervical spinal cord tissues developmental stage: Adult treatment: Control 5.12631
GSM611090 Control mouse 2 cervical spinal cord regions gender: Male strain: C57BL/6 tissue: Cervical spinal cord tissues developmental stage: Adult treatment: Control 4.88682
GSM611091 MPTP-treated mouse 1 cervical spinal cord regions gender: Male strain: C57BL/6 tissue: Cervical spinal cord tissues developmental stage: Adult treatment: MPTP-treated 5.41202
GSM611092 MPTP-treated mouse 2 cervical spinal cord regions gender: Male strain: C57BL/6 tissue: Cervical spinal cord tissues developmental stage: Adult treatment: MPTP-treated 5.62057
GSM611093 MPTP and acupoints acupuncture-treated mouse 1 cervical spinal cord regions gender: Male strain: C57BL/6 tissue: Cervical spinal cord tissues developmental stage: Adult treatment: MPTP and acupoints acupuncture-treated 5.45911
GSM611094 MPTP and acupoints acupuncture-treated mouse 2 cervical spinal cord regions gender: Male strain: C57BL/6 tissue: Cervical spinal cord tissues developmental stage: Adult treatment: MPTP and acupoints acupuncture-treated 5.47957
GSM611095 MPTP and nonacupoints acupuncture-treated mouse 1 cervical spinal cord regions gender: Male strain: C57BL/6 tissue: Cervical spinal cord tissues developmental stage: Adult treatment: MPTP and nonacupoints acupuncture-treated 5.39078
GSM611096 MPTP and nonacupoints acupuncture-treated mouse 2 cervical spinal cord regions gender: Male strain: C57BL/6 tissue: Cervical spinal cord tissues developmental stage: Adult treatment: MPTP and nonacupoints acupuncture-treated 5.44708

ID GSE24838
Title Gene expression data from brain striatal and spinal cord regions of MPTP-intoxicated mouse following acupuncture
Organism Mus musculus
GSM Sample info Characteristics Value
GSM611081 Control mouse 1 striatal regions gender: Male strain: C57BL/6 tissue: Striatal tissues developmental stage: Adult treatment: Control 4.69706
GSM611082 Control mouse 2 striatal regions gender: Male strain: C57BL/6 tissue: Striatal tissues developmental stage: Adult treatment: Control 4.86593
GSM611083 MPTP-treated mouse 1 striatal regions gender: Male strain: C57BL/6 tissue: Striatal tissues developmental stage: Adult treatment: MPTP-treated 4.71109
GSM611084 MPTP-treated mouse 2 striatal regions gender: Male strain: C57BL/6 tissue: Striatal tissues developmental stage: Adult treatment: MPTP-treated 4.54749
GSM611085 MPTP and acupoints acupuncture-treated mouse 1 striatal regions gender: Male strain: C57BL/6 tissue: Striatal tissues developmental stage: Adult treatment: MPTP and acupoints acupuncture-treated 4.46335
GSM611086 MPTP and acupoints acupuncture-treated mouse 2 striatal regions gender: Male strain: C57BL/6 tissue: Striatal tissues developmental stage: Adult treatment: MPTP and acupoints acupuncture-treated 5.12315
GSM611087 MPTP and nonacupoints acupuncture-treated mouse 1 striatal regions gender: Male strain: C57BL/6 tissue: Striatal tissues developmental stage: Adult treatment: MPTP and nonacupoints acupuncture-treated 4.70307
GSM611088 MPTP and nonacupoints acupuncture-treated mouse 2 striatal regions gender: Male strain: C57BL/6 tissue: Striatal tissues developmental stage: Adult treatment: MPTP and nonacupoints acupuncture-treated 4.56652
GSM611089 Control mouse 1 cervical spinal cord regions gender: Male strain: C57BL/6 tissue: Cervical spinal cord tissues developmental stage: Adult treatment: Control 5.12631
GSM611090 Control mouse 2 cervical spinal cord regions gender: Male strain: C57BL/6 tissue: Cervical spinal cord tissues developmental stage: Adult treatment: Control 4.88682
GSM611091 MPTP-treated mouse 1 cervical spinal cord regions gender: Male strain: C57BL/6 tissue: Cervical spinal cord tissues developmental stage: Adult treatment: MPTP-treated 5.41202
GSM611092 MPTP-treated mouse 2 cervical spinal cord regions gender: Male strain: C57BL/6 tissue: Cervical spinal cord tissues developmental stage: Adult treatment: MPTP-treated 5.62057
GSM611093 MPTP and acupoints acupuncture-treated mouse 1 cervical spinal cord regions gender: Male strain: C57BL/6 tissue: Cervical spinal cord tissues developmental stage: Adult treatment: MPTP and acupoints acupuncture-treated 5.45911
GSM611094 MPTP and acupoints acupuncture-treated mouse 2 cervical spinal cord regions gender: Male strain: C57BL/6 tissue: Cervical spinal cord tissues developmental stage: Adult treatment: MPTP and acupoints acupuncture-treated 5.47957
GSM611095 MPTP and nonacupoints acupuncture-treated mouse 1 cervical spinal cord regions gender: Male strain: C57BL/6 tissue: Cervical spinal cord tissues developmental stage: Adult treatment: MPTP and nonacupoints acupuncture-treated 5.39078
GSM611096 MPTP and nonacupoints acupuncture-treated mouse 2 cervical spinal cord regions gender: Male strain: C57BL/6 tissue: Cervical spinal cord tissues developmental stage: Adult treatment: MPTP and nonacupoints acupuncture-treated 5.44708

ID GSE26364
Title Gene expression changes in alpha GABA receptors in the mice brains after prolonged ketamine administration
Organism Mus musculus
GSM Sample info Characteristics Value
GSM647254 Saline PFC 1 strain: ICR tissue: prefrontal cortex Sex: female 4.99365
GSM647255 Saline PFC 2 strain: ICR tissue: prefrontal cortex Sex: female 4.64165
GSM647256 Ketamine PFC 1 strain: ICR tissue: prefrontal cortex Sex: female 7.63408
GSM647257 Ketamine PFC 2 strain: ICR tissue: prefrontal cortex Sex: female 7.2826

ID GSE35138
Title Gene expression data from thalamic regions of MPTP-intoxicated mouse brain by acupuncture
Organism Mus musculus
GSM Sample info Characteristics Value
GSM862520 Control mouse 1 thalamic regions gender: Male strain: C57BL/6 tissue: thalamic tissues developmental stage: Adult 5.85861
GSM862521 Control mouse 2 thalamic regions gender: Male strain: C57BL/6 tissue: thalamic tissues developmental stage: Adult 5.95936
GSM862522 MPTP-treated mouse 1 thalamic regions gender: Male strain: C57BL/6 tissue: thalamic tissues developmental stage: Adult 4.3834
GSM862523 MPTP-treated mouse 2 thalamic regions gender: Male strain: C57BL/6 tissue: thalamic tissues developmental stage: Adult 4.9311
GSM862524 MPTP and acupoints acupuncture-treated mouse 1 thalamic regions gender: Male strain: C57BL/6 tissue: thalamic tissues developmental stage: Adult 4.53678
GSM862525 MPTP and acupoints acupuncture-treated mouse 2 thalamic regions gender: Male strain: C57BL/6 tissue: thalamic tissues developmental stage: Adult 4.34374
GSM862526 MPTP and nonacupoints acupuncture-treated mouse 1 thalamic regions gender: Male strain: C57BL/6 tissue: thalamic tissues developmental stage: Adult 4.56434
GSM862527 MPTP and nonacupoints acupuncture-treated mouse 2 thalamic regions gender: Male strain: C57BL/6 tissue: thalamic tissues developmental stage: Adult 4.72705

ID GSE48293
Title Gene expression data from substantia nigral regions of MPTP-intoxicated mouse brain by acupuncture
Organism Mus musculus
GSM Sample info Characteristics Value
GSM1174263 Control mouse 1 substantia nigral regions gender: Male strain: C57BL/6 tissue: substantia nigral tissues developmental stage: Adult treatment: Control 4.29669
GSM1174264 Control mouse 2 substantia nigral regions gender: Male strain: C57BL/6 tissue: substantia nigral tissues developmental stage: Adult treatment: Control 6.06297
GSM1174265 MPTP-treated mouse 1 substantia nigral regions gender: Male strain: C57BL/6 tissue: substantia nigral tissues developmental stage: Adult treatment: MPTP-treated 6.41897
GSM1174266 MPTP-treated mouse 2 substantia nigral regions gender: Male strain: C57BL/6 tissue: substantia nigral tissues developmental stage: Adult treatment: MPTP-treated 5.61316
GSM1174267 MPTP and acupoints acupuncture-treated mouse 1 substantia nigral regions gender: Male strain: C57BL/6 tissue: substantia nigral tissues developmental stage: Adult treatment: MPTP and acupoints acupuncture-treated 6.24682
GSM1174268 MPTP and acupoints acupuncture-treated mouse 2 substantia nigral regions gender: Male strain: C57BL/6 tissue: substantia nigral tissues developmental stage: Adult treatment: MPTP and acupoints acupuncture-treated 6.38544
GSM1174269 MPTP and nonacupoints acupuncture-treated mouse 1 substantia nigral regions gender: Male strain: C57BL/6 tissue: substantia nigral tissues developmental stage: Adult treatment: MPTP and nonacupoints acupuncture-treated 6.04351
GSM1174270 MPTP and nonacupoints acupuncture-treated mouse 2 substantia nigral regions gender: Male strain: C57BL/6 tissue: substantia nigral tissues developmental stage: Adult treatment: MPTP and nonacupoints acupuncture-treated 5.56538